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Construction of The RGFP Transgene Encoding mir-302s (RGFP-mir-302s).
The RGFP-mir-302s transgene was generated as previously reported with minor modifications (Lin and Ying, 2006) . The mir-302 familial cluster consists of four parts, including precursor miRNAs (pre-miRNAs) of mir-302a, b, c, and d. Synthetic oligonucleotides (Sigma-Genosys, St. Louis, MO) were listed in Table S1 . We first hybridized mir-302a-sense to mir-302a-antisense, mir-302b-sense to mir-302b-antisense, mir-302c-sense to mir-302c-antisense, and mir-302d-sense to mir-302d-antisense, respectively, at 94°C for 2 min, at 70°C for 20 min, and then at 4°C in 1 x PCR buffer. Next, the hybrids (100 pmole each) of mir-302a, mir-302b, mir-302c, and mir-302d were separately digested with MluI/XhoI, XhoI/NdeI, NdeI/XbaI, and XbaI/PvuI restriction enzymes, respectively, at 37°C for 4 hours. The digested hybrids were mixed together and collected with a gel extraction filter (Qiagen, Valencia, CA) in 30 l of autoclaved ddH 2 O. Immediately after that, the mir-302 cluster was formed by ligation of all four hybrids with T4 DNA ligase (20 units) at 8°C for 16 hours. For insertion into RGFP intron, we mixed an equal amount (1:1) of the mir-302 cluster and a pre-made SpRNAi-RGFP transgene vector from our previous study (Lin et al., 2008) , and then digested the mixture with MluI/PvuI restriction enzymes at 37°C for 4 hours. The digested mixture was collected with a gel extraction filter in 30 l of ddH 2 O and ligated together with T 4 DNA ligase at 8°C for 16 hours. This formed the RGFP-mir-302s transgene, which could be further cleaved out of the vector with XhoI/HindIII digestion.
Construction of The Inducible pTet-On-tTS-mir302s Vector.
We first modified a Dox-inducible pSingle-tTS-shRNA vector (Clontech, Palo Alto, CA) by replacing its U6 promoter with a TRE-CMV promoter isolated from a pTRE-Tight plasmid (Clontech). Then, the modified vector was digested with XhoI/HindIII restriction enzymes at 37°C for 4 hours, purified by a gel extraction filter in 30 l of ddH 2 O, and then mixed and ligated with the XhoI/HindIII-cleaved RGFP-mir-302s transgene (1:1) with T 4 DNA ligase at 8°C for 16 hours. This formed the inducible pTet-On-tTS-mir302s vector. Given that the pTet-On-tTSmiR302s vector concurrently expressed a tetracycline-controlled regulatory protein (tTS) to control the transcriptional activity of the TRE-CMV promoter, the induction of mir-302 expression was achieved by using just a single vector, which significantly improved the efficiency and convenience of conventional Tet-On gene induction systems. Further, we also modified another Dox-inducible pTet-On-Advanced vector (Clontech) by removing its neomycin-resistant gene (Neo (Fig. 1A) was transduced into adult hHFC by electroporation at 300-400 volts for 150 sec in a hypo-osmolar PH buffer (200 l; Eppendorf). In each test, 10 g of the pTet-On-tTS-miR302s vector was used to transfect 200,000 cultured hHFC derived from as few as two human hair follicles (dermal papilla). After doxycycline (Dox)-induced expression, the biogenesis of mir-302 relied on the natural intronic miRNA pathway, in which the mir-302 cluster (supplementary Fig. 1A ) was co-expressed with the encoded RGFP gene transcripts and further processed into individual mir-302 molecules by RNA splicing enzymes (spliceosomal components) and RNaseIII Dicers (Lin et al., 2008) . . Pluripotency. Various tissue types were found in teratoma-like cysts derived from mirPS-NT cells, containing all three embryonic germ layers. Tissue markers: skin epidermis with keratin 14 and 16, hair follicle with microphthalmia-associated transcription factor (Mitf) and TRP1, skeleton muscle with M-cadherin and myosin heayy chain (MHC), smooth muscle with actin alpha 2 in smooth muscle aorta (a-SMS, ACTA2) and ED-A fibronectin, endothelium with CD105 and EN4 antigen, gut with mucin 2 (MUC2) and 5B (MUC5B), and gland and glandular epithelium with MUC2, secretory component glycoprotein (SC), glutamic-acid decarboxylase (GAD67) and/or bone morphogenetic protein 11 (BMP11). H&E, histological staining with hematoxylin and eosin. BF, bright field with differential interference contrast. Table S1 . Table S2 . 
